Matches in SemOpenAlex for { <https://semopenalex.org/work/W4308336321> ?p ?o ?g. }
- W4308336321 endingPage "5403" @default.
- W4308336321 startingPage "5403" @default.
- W4308336321 abstract "Immune checkpoint inhibitors (ICIs) have revolutionized the therapeutic scenario for several malignancies. However, they can be responsible for immune-related adverse events (irAEs), involving several organs, with a pooled incidence ranging between 54% and 76%. The frequency of cardiovascular system involvement is <1%. Among the cardiovascular irAEs, myocarditis is the most common and the most dangerous but other, less common manifestations of ICI-related cardiotoxicity include pericardial disease, arrhythmias, Takotsubo-like syndrome, and acute myocardial infarction, all of which remain poorly explored. Both oncologists and cardiologists, as well as the patients, should be aware of the possible occurrence of one or more of these complications, which in some cases are fatal, in order to implement effective strategies of cardiac surveillance. In this review, we summarize the latest studies and recommendations on the pathogenesis, clinical manifestation, diagnosis, and management of ICI-related cardiotoxicity in order to realize a complete and updated overview on the main aspects of ICI-related cardiotoxicity, from surveillance to diagnosis to management, useful for both oncologists and cardiologists in their clinical practice. In particular, in the first part of the review, we realize a description of the pathogenetic mechanisms and risk factors of the main cardiovascular irAEs. Then, we focus on the management of ICI-related cardiotoxicity by analyzing five main points: (1) identifying and evaluating the type and severity of the cardiotoxicity; (2) deciding whether to withhold ICI therapy; (3) initiating steroid and immunosuppressive therapy; (4) starting conventional cardiac treatment; and (5) restarting ICI therapy. Finally, we discuss the existing evidence on surveillance for ICI-related cardiotoxicity and propose a surveillance strategy for both short- and long-term cardiotoxicity, according to the most recent guidelines." @default.
- W4308336321 created "2022-11-11" @default.
- W4308336321 creator A5012096745 @default.
- W4308336321 creator A5031740540 @default.
- W4308336321 creator A5053611466 @default.
- W4308336321 creator A5057753126 @default.
- W4308336321 creator A5059144188 @default.
- W4308336321 creator A5062541128 @default.
- W4308336321 creator A5086984759 @default.
- W4308336321 creator A5091150576 @default.
- W4308336321 date "2022-11-02" @default.
- W4308336321 modified "2023-10-18" @default.
- W4308336321 title "Cardiotoxicity Induced by Immune Checkpoint Inhibitors: What a Cardio-Oncology Team Should Know and Do" @default.
- W4308336321 cites W1988995773 @default.
- W4308336321 cites W2012072922 @default.
- W4308336321 cites W2092830781 @default.
- W4308336321 cites W2096322385 @default.
- W4308336321 cites W2098853737 @default.
- W4308336321 cites W2109719586 @default.
- W4308336321 cites W2117552772 @default.
- W4308336321 cites W2122132866 @default.
- W4308336321 cites W2126116248 @default.
- W4308336321 cites W2140419562 @default.
- W4308336321 cites W2195401421 @default.
- W4308336321 cites W2290758374 @default.
- W4308336321 cites W2296110227 @default.
- W4308336321 cites W2547133566 @default.
- W4308336321 cites W2560367415 @default.
- W4308336321 cites W2599761051 @default.
- W4308336321 cites W2606119756 @default.
- W4308336321 cites W2612002454 @default.
- W4308336321 cites W2612667367 @default.
- W4308336321 cites W2620860824 @default.
- W4308336321 cites W2744958889 @default.
- W4308336321 cites W2760893760 @default.
- W4308336321 cites W2761586559 @default.
- W4308336321 cites W2768429453 @default.
- W4308336321 cites W2769229435 @default.
- W4308336321 cites W2769632314 @default.
- W4308336321 cites W2781585655 @default.
- W4308336321 cites W2783137027 @default.
- W4308336321 cites W2789315292 @default.
- W4308336321 cites W2791265590 @default.
- W4308336321 cites W2791446054 @default.
- W4308336321 cites W2793167197 @default.
- W4308336321 cites W2795067517 @default.
- W4308336321 cites W2804734521 @default.
- W4308336321 cites W2883628501 @default.
- W4308336321 cites W2888880602 @default.
- W4308336321 cites W2891486030 @default.
- W4308336321 cites W2892351219 @default.
- W4308336321 cites W2894551604 @default.
- W4308336321 cites W2901191795 @default.
- W4308336321 cites W2903759577 @default.
- W4308336321 cites W2909507870 @default.
- W4308336321 cites W2913202760 @default.
- W4308336321 cites W2924287598 @default.
- W4308336321 cites W2949277199 @default.
- W4308336321 cites W2950056455 @default.
- W4308336321 cites W2969473108 @default.
- W4308336321 cites W2969583767 @default.
- W4308336321 cites W2970308936 @default.
- W4308336321 cites W2972277073 @default.
- W4308336321 cites W2974858560 @default.
- W4308336321 cites W2976692781 @default.
- W4308336321 cites W2979167769 @default.
- W4308336321 cites W2986848258 @default.
- W4308336321 cites W2987385271 @default.
- W4308336321 cites W3003308809 @default.
- W4308336321 cites W3003658181 @default.
- W4308336321 cites W3004915713 @default.
- W4308336321 cites W3007666278 @default.
- W4308336321 cites W3008681897 @default.
- W4308336321 cites W3009244677 @default.
- W4308336321 cites W3010228870 @default.
- W4308336321 cites W3013337466 @default.
- W4308336321 cites W3025232850 @default.
- W4308336321 cites W3040275902 @default.
- W4308336321 cites W3082188176 @default.
- W4308336321 cites W3084285067 @default.
- W4308336321 cites W3089761109 @default.
- W4308336321 cites W3089951997 @default.
- W4308336321 cites W3094729838 @default.
- W4308336321 cites W3094895935 @default.
- W4308336321 cites W3097476195 @default.
- W4308336321 cites W3108805504 @default.
- W4308336321 cites W3112795121 @default.
- W4308336321 cites W3118557256 @default.
- W4308336321 cites W3120657480 @default.
- W4308336321 cites W3121619063 @default.
- W4308336321 cites W3127189789 @default.
- W4308336321 cites W3129124969 @default.
- W4308336321 cites W3138922415 @default.
- W4308336321 cites W3139459175 @default.
- W4308336321 cites W3149397307 @default.
- W4308336321 cites W3150964840 @default.
- W4308336321 cites W3158326626 @default.
- W4308336321 cites W3166573676 @default.